
Invitae Corporation NVTA
Quarterly report 2023-Q3
added 11-08-2023
Invitae Corporation EV - Enterprise Value 2011-2026 | NVTA
Annual EV - Enterprise Value Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.11 B | 3.39 B | 7.99 B | 2.03 B | 943 M | 403 M | 240 M | 143 M | 105 M | 47.3 M | 38.7 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.99 B | 38.7 M | 1.58 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 16.65 | -12.64 % | $ 179 M | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 24.69 | - | $ 686 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 114.87 | - | $ 34.9 B | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
15.3 B | $ 126.92 | - | $ 20.2 B | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 83.55 | - | $ 5.64 B | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 27.12 | - | $ 20 B | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 1.63 | - | $ 2.17 M | ||
|
Personalis
PSNL
|
229 M | $ 5.5 | - | $ 326 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 21.91 | - | $ 1.17 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Senseonics Holdings
SENS
|
376 M | $ 7.18 | - | $ 300 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 15.3 | - | $ 463 M | ||
|
Trinity Biotech plc
TRIB
|
133 M | $ 0.61 | - | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 59.15 | - | $ 3.54 B | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 166.79 | 0.05 % | $ 8.27 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
15.2 B | $ 83.09 | - | $ 10.4 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 1.93 | - | $ 8.54 M | ||
|
Exagen
XGN
|
78.4 M | $ 2.73 | -0.36 % | $ 58.9 M | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Medpace Holdings
MEDP
|
14 B | $ 409.65 | - | $ 11.8 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.18 | -0.46 % | $ 5.01 M | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 102.49 | - | $ 8.45 B | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 259.57 | - | $ 21.6 B | ||
|
NeoGenomics
NEO
|
1.85 B | $ 9.02 | - | $ 1.16 B | ||
|
Celcuity
CELC
|
5.57 B | $ 120.07 | - | $ 5.61 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.34 | - | $ 2.03 B | ||
|
National Research Corporation
NRC
|
432 M | $ 16.84 | -1.58 % | $ 377 M | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.84 | - | $ 448 M | ||
|
Natera
NTRA
|
5.53 B | $ 200.17 | - | $ 19.7 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 195.05 | - | $ 21.7 B | ||
|
OpGen
OPGN
|
10.3 M | - | -16.95 % | $ 1.54 M |